NEW YORK (GenomeWeb) – Bio-Techne announced today that it has agreed to acquire Advanced Cell Diagnostics for $250 million in cash, plus an additional consideration of $75 million if certain milestones are achieved.

The deal is expected to close on or about August 1, and will be financed through a combination of cash on hand and a revolving line of credit facility that Bio-Techne said it expects to obtain. The company expects the acquisition to be slightly dilutive to its adjusted earnings per share for fiscal year 2017, and accretive thereafter.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.